Janssen Liable For $5.6M In Risperdal Death Trial In California State Court
Mealey's (October 20, 2015, 1:20 PM EDT) -- LOS ANGELES — A California state court jury on Oct. 16 found that Janssen Research and Development LLC was negligent in a Risperdal clinical trial that resulted in the death of a 25-year-old schizophrenic man, and the court entered judgment against the defendant for $5.6 million for its share of liability (Augustine Liu, et al. v. Johnson & Johnson, et al., No. BC432264, Calif. Super., Los Angeles Co.).